C. Meier

First name
C.
Middle name
R.
Last name
Meier
Schneider, C., Jick, S. S., Bothner, U., & Meier, C. R. (2010). COPD and the risk of depression. Chest. http://doi.org/10.1378/chest.09-0614
Bodmer, M., Brauchli, Y. B., Jick, S. S., & Meier, C. R. (2011). Diabetes mellitus and the risk of cholecystectomy. Dig Liver Dis. http://doi.org/10.1016/j.dld.2011.04.014
Bodmer, M., Becker, C., Jick, S. S., & Meier, C. R. (2012). Metformin does not alter the risk of lung cancer: a case-control analysis. Lung Cancer. http://doi.org/10.1016/j.lungcan.2012.08.010
Imfeld, P., Bodmer, M., Jick, S. S., & Meier, C. R. (2012). Metformin, other antidiabetic drugs, and risk of Alzheimer\textquoterights disease: a population-based case-control study. J Am Geriatr Soc. http://doi.org/10.1111/j.1532-5415.2012.03916.x
Spoendlin, J., Voegel, J. J., Jick, S. S., & Meier, C. R. (2012). A study on the epidemiology of rosacea in the U.K. Br J Dermatol. http://doi.org/10.1111/j.1365-2133.2012.11037.x
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2012). Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. Am J Gastroenterol. http://doi.org/10.1038/ajg.2011.483
Bodmer, M., Becker, C., Meier, C., Jick, S. S., & Meier, C. R. (2012). Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-11-0992-t
Amar, R. K., Jick, S. S., Rosenberg, D., Maher, T. M., & Meier, C. R. (2012). Drug-/radiation-induced interstitial lung disease in the United Kingdom general population: incidence, all-cause mortality and characteristics at diagnosis. Respirology. http://doi.org/10.1111/j.1440-1843.2012.02187.x
Amar, R. K., Jick, S. S., Rosenberg, D., Maher, T. M., & Meier, C. R. (2012). Incidence of the pneumoconioses in the United Kingdom general population between 1997 and 2008. Respiration. http://doi.org/10.1159/000338116
Hong, J. L., Meier, C. R., Sandler, R. S., Jick, S. S., & Sturmer, T. (2013). Risk of colorectal cancer after initiation of orlistat: matched cohort study. Bmj. http://doi.org/10.1136/bmj.f5039